Survival rates for patients with certain types of breast and lung cancers were better at National Cancer Institute (NCI)-designated comprehensive cancer centers than at other kinds of hospitals, according to an anlysis involving nearly 370,000 individuals. Investigators used the National Cancer Data Base to analyze survival in patients with stage III breast (n=116,787) and stage IIIB or IV non–small-cell lung (n=252,392) cancers. Among the results:
- After adjustment at the hospital level, few hospitals had statistically better or worse survival rates.
- By hospital type, survival rates were significantly better at NCI–designated comprehensive cancer centers than they were at academic cancer centers and community hospitals.
Shulman L, Palis B, McCabe R, et al. Survival as a quality metric of cancer care: Use of the National Cancer Data Base to assess hospital performance. [Published online ahead of print November 1, 2017]. J Oncol Pract. doi:10.1200/JOP.2016.020446.
This Week's Must Reads
Abemaciclib as Initial Therapy for Advanced BC, J Clin Oncol; 2017 Nov 10; Goetz, Toi, et al
BC Recurrence Risk Post-Endocrine Therapy Assessed, N Engl J Med; 2017 Nov 9; Pan, Gray, et al
The Value of an Embedded Palliative Care Program, Breast Cancer Res Treat; ePub 2017 Oct 30; Rabow, et al
Does Weight Gain Impact BC Disease Recurrence?, Clin Breast Cancer; ePub 2017 Nov 8; Raghavendra, et al
Abemaciclib + Fulvestrant in Advanced BC Evaluated, J Clin Oncol; 2017 Sep 1; Sledge, Toi, et al
Must Reads in Practice Management
Survival as a Quality Metric of Cancer Care, J Oncol Pract; ePub 2017 Nov 1; Shulman, et al
Prostate Ca Outcomes by Insurance Type Assessed, Cancer; ePub 2017 Oct 30; Mahal, Mahal, et al
Impact of Insurance Type on Head and Neck Cancer, Cancer; ePub 2017 Nov 7; Gupta, Sonis, et al
Care Transitions in Patients with Advanced Cancer, J Clin Oncol; ePub 2017 Oct 25; Lage, et al
Racial and Ethnic Disparities in Cancer Survival, J Clin Oncol; ePub 2017 Oct 16; Ellis, et al